Method of producing a polypeptide or virus of interest in a continuous cell culture
AssigneeBaxalta Incorporated
InventorsLeopold Grillberger, Manfred Reiter, Daniel Fleischanderl
Life of this patent
Estimating the term…
Loading patent…
AssigneeBaxalta Incorporated
InventorsLeopold Grillberger, Manfred Reiter, Daniel Fleischanderl
Estimating the term…
Described herein is a chemostat-like continuous cell culture system that combines certain advantages of perfusion open systems and chemostat open systems to improve the culturing of mammalian cells, e.g., genetically modified cells, particularly in serum-free or chemically-defined media. The continuous culture system described herein involves culturing mammalian cells in a continuous cell culture system, which comprises a cell retention device, wherein the cell culture system has a dilution rate (D) of less than about 2 d−1, and a cell density of less than about 2×107 cell/mL. Also described herein is a method for producing a polypeptide and/or virus of interest in a continuous cell culture, the method comprising culturing mammalian cells expressing the polypeptide and/or virus of interest in a continuous cell culture system, which comprises a cell retention device, wherein the cell culture system has a dilution rate (D) of less than about 2 d−1, and a cell density of less than about 2×107 cell/mL; and recovering the polypeptide and/or virus of interest from medium of the cell culture system.
A method for producing a disintegrin-like and metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13) protein in a continuous cell culture, said method comprising
Dependencies are inferred from the claim text.